SCHEMBL4925930

SCHEMBL4925930

O=c1c(NCc2cccc(O)c2)c(Nc2ccc(O)c(-n3cccc3)c2)c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.44
HIF1A Q16665 1/20 0.42
RPS6KB1 P23443 7/20 0.42
GSK3B P49841 7/20 0.42
ROCK1 Q13464 7/20 0.42
PRKG1 Q13976 7/20 0.42
AURKB Q96GD4 7/20 0.42
CHEK2 O96017 6/20 0.42
PRKACA P17612 6/20 0.42
RPS6KA3 P51812 6/20 0.42
PKN2 Q16513 6/20 0.42
CDC42BPA Q5VT25 6/20 0.42
HIPK4 Q8NE63 6/20 0.42
CLK4 Q9HAZ1 6/20 0.42
GSK3A P49840 6/20 0.42
AKT1 P31749 5/20 0.42
ROCK2 O75116 5/20 0.42
CHEK1 O14757 5/20 0.42
MKNK2 Q9HBH9 5/20 0.42
SGK2 Q9HBY8 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4920526 0.88 ROCK1 (0.45) EGFRHIF1ARPS6KB1GSK3BROCK1
SCHEMBL4927504 0.84 GSK3B (0.43) EGFRHIF1ARPS6KB1GSK3BROCK1
SCHEMBL4917069 0.81 EGFR (0.50) EGFRHIF1ARPS6KB1GSK3BROCK1
SCHEMBL4919796 0.81 GSK3B (0.48) EGFRHIF1ARPS6KB1GSK3BROCK1
SCHEMBL4906887 0.80 MAPKAPK2 (0.54) EGFRHIF1ARPS6KB1GSK3BROCK1
SCHEMBL4916629 0.80 EGFR (0.49) EGFRHIF1ARPS6KB1GSK3BROCK1
SCHEMBL4917914 0.79 EGFR (0.46) EGFRHIF1ARPS6KB1GSK3BROCK1
SCHEMBL4916045 0.79 EGFR (0.57) EGFRHIF1ARPS6KB1GSK3BROCK1
SCHEMBL4599292 0.78 HIF1A (0.48) EGFRHIF1ARPS6KB1GSK3BROCK1
SCHEMBL4914009 0.78 EGFR (0.45) EGFRHIF1ARPS6KB1GSK3BROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312244-A1 Squaric Acid Derivatives as Protein Kinase Inhibitors MERCK PATENT GMBH (DE) 2008-12-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312244-A1 Squaric Acid Derivatives as Protein Kinase Inhibitors CHEK1, CHEK2, SIK1 EGFR 1602/4885HIF1A 1888/4885RPS6KB1 276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.